Primary immune thrombocytopenia in children
Primary immune thrombocytopenia (ITP) is usually a benign and self-limiting disease in children. Due to the complex pathogenesis involving different immunological processes, its course may be unpredictable. The goal of therapy is to prevent severe, dangerous bleeding, especially intracranial bleedin...
Main Authors: | Agnieszka Książek, Tomasz Szczepański |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2021-03-01
|
Series: | Pediatria Polska |
Subjects: | |
Online Access: | https://www.termedia.pl/Primary-immune-thrombocytopenia-in-children,127,43672,1,1.html |
Similar Items
-
How we treat primary immune thrombocytopenia in adults
by: Xin-guang Liu, et al.
Published: (2023-01-01) -
Response to rituximab in children and adults with immune thrombocytopenia (ITP)
by: Emily M. Harris, et al.
Published: (2021-08-01) -
Fibrinogen levels are associated with bleeding in patients with primary immune thrombocytopenia
by: Min Xu, et al.
Published: (2020-08-01) -
Gut microbiota alterations in children and their relationship with primary immune thrombocytopenia
by: Xiangyu Li, et al.
Published: (2023-06-01) -
Safety of Immunization for Children with Immune Thrombocytopenia
by: Xiangshi Wang, et al.
Published: (2024-01-01)